Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beta Bionics (BBNX) Change in Inventory (2024 - 2025)

Beta Bionics (BBNX) has disclosed Change in Inventory for 2 consecutive years, with $2.2 million as the latest value for Q4 2025.

  • Quarterly Change in Inventory rose 82.22% to $2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.9 million through Dec 2025, down 13.63% year-over-year, with the annual reading at $9.9 million for FY2025, 13.63% down from the prior year.
  • Change in Inventory hit $2.2 million in Q4 2025 for Beta Bionics, down from $3.3 million in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $3.9 million in Q3 2024 to a low of $1.2 million in Q4 2024.